These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16043316)

  • 1. Prevalence and correlates of hormonal therapy among Israeli women in the post-WHI era.
    Keinan-Boker L; Dictiar R; Garty N; Green MS
    Maturitas; 2005; 52(3-4):364-73. PubMed ID: 16043316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany.
    Heitmann C; Greiser E; Dören M
    Menopause; 2005; 12(4):405-11. PubMed ID: 16037755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of osteoporosis among Jewish and Arab women aged 45-74 in Israel: national women's health interview survey.
    Nitzan-Kaluski D; Chinich A; Ifrah A; Merom D; Green MS
    J Gend Specif Med; 2003; 6(1):17-23. PubMed ID: 12661173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
    Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
    Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing use of hormone therapy among minority women since the Women's Health Initiative.
    Helenius IM; Korenstein D; Halm EA
    Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ; Ma J; Stafford RS
    Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight, stature, and socioeconomic status among women--cause or effect: Israel National Women's Health Interview Survey, 1998.
    Kaluski DN; Chinich A; Leventhal A; Ifrah A; Cohen-Mannheim I; Merom D; Green MS
    J Gend Specif Med; 2001; 4(4):18-24. PubMed ID: 11727467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
    Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of recreational physical activity in women aged 50-64 years.
    McTiernan A; Stanford JL; Daling JR; Voigt LF
    Menopause; 1998; 5(2):95-101. PubMed ID: 9689203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for hormone therapy: the post-Women's Health Initiative era.
    Reed SD; Newton KM; Lacroix AZ
    Endocrinol Metab Clin North Am; 2004 Dec; 33(4):691-715. PubMed ID: 15501641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal symptoms in mid-life women in southern China.
    Yang D; Haines CJ; Pan P; Zhang Q; Sun Y; Hong S; Tian F; Bai B; Peng X; Chen W; Yang X; Chen Y; Feng H; Zhao S; Lei H; Jiang Z; Ma X; Liao W
    Climacteric; 2008 Aug; 11(4):329-36. PubMed ID: 18645699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy use over a decade in an Australian population.
    MacLennan AH; Wilson DH; Taylor AW
    Climacteric; 2002 Dec; 5(4):351-6. PubMed ID: 12626214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent reversal of trends in hormone therapy use in a European population.
    Morabia A; Costanza MC
    Menopause; 2006; 13(1):111-5. PubMed ID: 16607106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.